Answers are grounded in this paper and cite their sources.
Observational single-cell study reveals non-classical monocyte enrichment and immunosuppressive signaling in tuberculosis treatment non-responders, suggesting potential biomarkers of early failure.
Sputum culture conversion (SCC) at 2 months is an early indicator of tuberculosis (TB) treatment response, yet the associated immune alterations remain incompletely defined. We performed single-cell RNA sequencing on peripheral blood mononuclear cells from eight TB patients, stratified by 2-month SCC status. Non-responders showed a relative enrichment of non-classical monocytes and higher TB progression risk scores. CellChat analysis inferred altered IL16 and TRAIL communication involving these cells. CD4+ Tregs in non-responders showed higher LGALS9 expression and inferred GALECTIN signalling towards cytotoxic lymphocyte subsets; cell-level LGALS9 co-expression correlated with HAVCR2 and TIGIT in non-responders. Mature NK subclusters showed distinct enrichment profiles. These results describe an observational, transcriptomic and computationally inferred immune network associated with early treatment non-response. They generate candidate biomarkers and hypotheses for prospective protein-level and functional validation.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: